Deep learning-based prediction of deliverable adaptive plans for MR-guided adaptive radiotherapy: A feasibility study

被引:5
|
作者
Buchanan, Laura [1 ]
Hamdan, Saleh [1 ]
Zhang, Ying [1 ]
Chen, Xinfeng [1 ]
Li, X. Allen [1 ]
机构
[1] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
adaptive radiation therapy; MR-guided adaptive radiation therapy; online replanning; real-time adaptation; deep-learning;
D O I
10.3389/fonc.2023.939951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeFast and automated plan generation is desirable in radiation therapy (RT), in particular, for MR-guided online adaptive RT (MRgOART) or real-time (intrafractional) adaptive RT (MRgRART), to reduce replanning time. The purpose of this study is to investigate the feasibility of using deep learning to quickly predict deliverable adaptive plans based on a target dose distribution for MRgOART/MRgRART. MethodsA conditional generative adversarial network (cGAN) was trained to predict the MLC leaf sequence corresponding to a target dose distribution based on reference plan created prior to MRgOART using a 1.5T MR-Linac. The training dataset included 50 ground truth dose distributions and corresponding beam parameters (aperture shapes and weights) created during MRgOART for 10 pancreatic cancer patients (each with five fractions). The model input was the dose distribution from each individual beam and the output was the predicted corresponding field segments with specific shape and weight. Patient-based leave-one-out-cross-validation was employed and for each model trained, four (44 training beams) out of five fractionated plans of the left-out patient were set aside for testing purposes. We deliberately kept a single fractionated plan in the training dataset so that the model could learn to replan the patient based on a prior plan. The model performance was evaluated by calculating the gamma passing rate of the ground truth dose vs. the dose from the predicted adaptive plan and calculating max and mean dose metrics. ResultsThe average gamma passing rate (95%, 3mm/3%) among 10 test cases was 88%. In general, we observed 95% of the prescription dose to PTV achieved with an average 7.6% increase of max and mean dose, respectively, to OARs for predicted replans. Complete adaptive plans were predicted in <= 20 s using a GTX 1660TI GPU. ConclusionWe have proposed and demonstrated a deep learning method to generate adaptive plans automatically and rapidly for MRgOART. With further developments using large datasets and the inclusion of patient contours, the method may be implemented to accelerate MRgOART process or even to facilitate MRgRART.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Deep Learning-Based Automatic Plan Prediction for MR-Guided Adaptive Radiotherapy
    Buchanan, L.
    Zhang, Y.
    Chen, X.
    Li, X.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [2] Feasibility of Predicting Deliverable Daily Plans Using Deep Learning for MR-Guided Adaptive Radiation Therapy
    Hamdan, S.
    Nasief, H.
    Buchanan, L.
    Zhang, Y.
    Omari, E.
    Li, X.
    MEDICAL PHYSICS, 2022, 49 (06) : E201 - E202
  • [3] Deep Learning based Dose Prediction for MR-guided Radiotherapy
    Nachbar, M.
    Gutwein, S.
    Schneider, M.
    Zips, D.
    Baumgartner, C.
    Thorwarth, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S7 - S7
  • [4] Feasibility of Stereotactic MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
    Mustafayev, T. Z.
    Atalar, B.
    Gungor, G.
    Sengoz, M.
    Abacioglu, U.
    Ozyar, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E916 - E916
  • [5] Feasibility of neurovascular sparing MR-guided adaptive radiotherapy for prostate cancer
    Teunissen, F.
    Wortel, R.
    Hes, J.
    Willigenburg, T.
    de Boer, J.
    Meijer, R.
    van Melick, H.
    Verkooijen, H.
    van Zyp, J. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1126 - S1127
  • [6] Facilitating MR-Guided Adaptive Proton Therapy in Children Using Deep Learning-Based Synthetic CT
    Wang, Chuang
    Uh, Jinsoo
    Merchant, Thomas E.
    Hua, Chia-ho
    Acharya, Sahaja
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2022, 8 (03) : 11 - 20
  • [7] Editorial: Online Adaptive MR-Guided Radiotherapy
    Kerkmeijer, Linda G. W.
    Valentini, Vincenzo
    Fuller, Clifton D.
    Slotman, Ben J. J.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] MR-Guided Adaptive Radiotherapy for Bladder Cancer
    Hijab, Adham
    Tocco, Boris
    Hanson, Ian
    Meijer, Hanneke
    Nyborg, Christina Junker
    Bertelsen, Anders Smedegaard
    Smeenk, Robert Jan
    Smith, Gillian
    Michalski, Jeff
    Baumann, Brian C.
    Hafeez, Shaista
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Feasibility and first experience of MR-guided adaptive radiotherapy for head and neck cancer
    Balermpas, P.
    Krayenbuhl, J.
    Chamberlain, M.
    Bogowicz, M.
    Garcia-Schuler, H. I.
    Andratschke, N.
    Moreira, A. K.
    Wilke, L.
    Tanadini-Lang, S.
    Guckenberger, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S443 - S443
  • [10] Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
    Padgett, Kyle R.
    Simpson, Garrett N.
    Llorente, Ricardo
    Samuels, Michael A.
    Dogan, Nesrin
    CUREUS, 2018, 10 (04):